Contribution of glucose tolerance and gender to cardiac adiposity

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 11, 2009, Pages 4472-4482

  Iozzo, Patricia ^a,b   Lautamaki, Riikka ^a   Borra, Ronald ^a   Lehto, Hanna Riikka ^a   Bucci, Marco ^a,b   Viljanen, Antti ^a   Parkka, Jussi ^a   Lepomaki, Virva ^a   Maggio, Romina ^a   Parkkola, Riitta ^a   Knuuti, Juhani ^a   Nuutila, Pirjo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; TRIACYLGLYCEROL;

ABDOMINAL SUBCUTANEOUS FAT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HUMAN; HYPERGLYCEMIA; INTRAABDOMINAL FAT; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SPECTROSCOPY; STEATOSIS;

EID: 70449086246     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0436     Document Type: Article

References (45)

1. Perseghin G 2005 Muscle lipid metabolism in the metabolic syndrome. Curr Opin Lipidol 16:416-420 (Pubitemid 41017625)
2. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, Schminke U, Kessler C, John U 2005 Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11:1848-1853 (Pubitemid 40520783)
3. Després JP 2006 Is visceral obesity the cause of the metabolic syndrome? Ann Med 38:52-63
4. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH 2000 Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97:1784-1789 (Pubitemid 30118520)
5. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F 2003 Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163-5168 (Pubitemid 37452712)
6. Lamb HJ, Smit JW, van der Meer RW, Hammer S, Doornbos J, de Roos A, Romijn JA 2008 Metabolic MRI of myocardial and hepatic triglyceride content in response to nutritional interventions. Curr Opin Clin Nutr Metab Care 11:573-579
7. Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, Meinders EA, Romijn JA, de Roos A, Smit JW 2008 Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 52:1006-1012
8. Kankaanpää M, Lehto HR, Pärkkä JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P 2006 Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91:4689-4695 (Pubitemid 44833458)
9. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG 2003 Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49:417-423 (Pubitemid 36262808)
10. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS 2007 Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116:1170-1175 (Pubitemid 47360218)
11. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ 2008 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52:1793-1799
12. Kannel WB, McGee DL 1979 Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2:120-126
13. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD 2004 Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53:585-590 (Pubitemid 38270626)
14. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA 2004 Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200-206 (Pubitemid 38183882)
15. Dyck JR 2007 The ischemic heart: starving to stimulate the adiponectin-AMPK signaling axis. Circulation 116:2779-2781
16. Iacobellis G, Barbaro G, Gerstein HC 2008 Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol 128:424-426
17. Lautamäki R, Airaksinen KE, Seppänen M, Toikka J, Luotolahti M, Ball E, Borra R, Härkönen R, Iozzo P, Stewart M, Knuuti J, Nuutila P 2005 Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study. Diabetes 54:2787-2794 (Pubitemid 41233603)
18. Papavassiliu T, Kühl HP, Schröder M, Süselbeck T, Bondarenko O, Böhm CK, Beek A, Hofman MM, van Rossum AC 2005 Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging. Radiology 236:57-64 (Pubitemid 40853294)
19. Virtanen KA, Hällsten K, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Knuuti J, Huupponen R, Lönnroth P, Nuutila P 2003 Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes 52:283-290 (Pubitemid 36173180)
20. Abate N, Garg A, Coleman R, Grundy SM, Peshock RM 1997 Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 65:403-408 (Pubitemid 27130746)
21. Provencher SW 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
22. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT 1999 Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276(5 Pt 1):E977-E989 (Pubitemid 29249618)
23. Nikolaidis MG, Petridou A, Mougios V 2006 Comparison of the phospholipid and triacylglycerol fatty acid profile of rat serum, skeletal muscle and heart. Physiol Res 55:259-265 (Pubitemid 43911044)
24. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O 1994 Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495 (Pubitemid 24113193)
25. Clarke NE, Mosher RE 1952 The water and electrolyte content of the human heart in congestive heart failure with and without digitalization. Circulation 5:907-914
26. McGavock JM, Victor RG, Unger RH, Szczepaniak LS 2006 Adiposity of the heart, revisited. Ann Intern Med 144:517-524
27. Wang CP, Hsu HL, Hung WC, Yu TH, Chen YH, Chiu CA, Lu LF, Chung FM, Shin SJ, Lee YJ 2009 Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf) 70:876-882
28. Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS 2007 Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med 55:230-236 (Pubitemid 47555941)
29. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F 2003 Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304-310 (Pubitemid 41127400)
30. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS 2008 Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117:605-613
31. Tan CY, Vidal-Puig A 2008 Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 36(Pt 5):935-940
32. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R 2008 High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 57:367-371
33. Iacobellis G, Willens HJ, Barbaro G, Sharma AM 2008 Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 16:887-892
34. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET 1998 Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21:1258-1265
35. Jain SH, Massaro JM, Hoffmann U, Rosito GA, Vasan RS, Raji A, O'Donnell CJ, Meigs JB, Fox CS 2009 Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 32:903-908
36. Palanivel R, Fang X, Park M, Eguchi M, Pallan S, De Girolamo S, Liu Y, Wang Y, Xu A, Sweeney G 2007 Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc Res 75:148-157 (Pubitemid 46873521)
37. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K 2004 Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389 (Pubitemid 40022722)
38. Hopkins TA, Ouchi N, Shibata R, Walsh K 2007 Adiponectin actions in the cardiovascular system. Cardiovasc Res 74:11-18
39. Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, Levy D, Larson MG, D'Agostino Sr RB, O'Donnell CJ, Manning WJ 2009 Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 119:1586-1591
40. Goodpaster BH, He J, Watkins S, Kelley DE 2001 Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86:5755-5761 (Pubitemid 33152620)
41. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG 2002 Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51:3020-3024
42. Hammer S, van der Meer RW, Lamb HJ, Schär M, de Roos A, Smit JW, Romijn JA 2008 Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 93:497-503 (Pubitemid 351240822)
43. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H 2004 Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18:1692-1700 (Pubitemid 39463708)
44. Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl U, Tittus J, Parhofer K, Becker C, Reiser M, Knez A, Leber AW 2009 Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 29:781-786
45. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, O'Donnell CJ, Fox CS, Hoffmann U 2009 Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30:850-856